Insertion of the Bacterial Gpt Gene Into the Germ Line of Mice by Retroviral

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Proc. Nati. Acad. Sci. USA Vol. 82, pp. 6927-6931, October 1985 Cell Biology Insertion of the bacterial gpt gene into the germ line of mice by retroviral infection (preimplantation mouse embryos/germ-line integration/DNA methylatlon/5-azacytidine/gene expression) DETLEV JAHNER*t, KIRSTEN HAASE*, RICHARD MULLIGANt, AND RUDOLF JAENISCH*t *Heinrich-Pette-Institut fur Experimentelle Virologie und Immunologie an der Universitat Hamburg, Martinistr. 52, 2000 Hamburg 20, Federal Republic of Germany; and tWhitehead Institute for Biomedical Research, and Department of Biology, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142 Communicated by Robert A. Weinberg, July 1, 1985 ABSTRACT Mouse substrains genetically transmitting the Retroviral vectors have been constructed that can exogenous Moloney murine leukemia virus (Mo-MuLV) at a transduce foreign genes into a variety ofcell types (12-22). In single locus have been derived previously by infection of previous experiments, a vector transducing a bacterial mark- preimplantation embryos. Here we explore the potential of er gene has been introduced into postimplantation mouse retroviral vectors for transferring nonviral genes into the germ embryos by injection of virus, and the transduced gene was line ofmice. Preimplantation mouse embryos were cocultivated shown to be active in many somatic tissues ofanimals derived with a cell line that produces a recombinant retrovirus whose from injected embryos (17). Viral insertion into germ line genome carries the Escherichia cofi gene gpt. We show that the cells was, however, not obtained in these experiments. vector sequence was inserted into the genome of the embryo To explore the potential of retroviral vectors to transfer and into the germ line at a frequency similar to that for the nonretroviral genes into the germ line of mice, we have Mo-MuLV-helper sequence. A new mouse strain, Mgpt-1, was exposed preimplantation embryos to MSVgpt virus, which is developed that is homozygous for a single MSVgpt proviral a Mo-MuLV-derived vector carrying the Escherichia coli genome. The proviral sequences were highly methylated and gene gpt. We show that the vector is inserted into germ-line not expressed in tissues of Mgpt-1 mice. When cells derived cells at a similar frequency as Mo-MuLV helper virus. The from transgeneic animals were treated with 5-azacytidine, the inserted gene is highly methylated and transcriptionally proviral sequences were not methylated and were transcrip- inactive but can be activated by treatment of cells with tionally activated. These results indicate that nonviral genes 5-azacytidine. that are under the control of the viral long terminal repeat are inactivated when transferred into the germ line of animals. MATERIALS AND METHODS The transfer of foreign genes into an animal's germ line represents a powerful tool for the study of gene regulation Mice. Embryos were derived from mice of strain 129. The during mammalian development. To date, the primary meth- origin of Mov-9 and Mov-13 mice has been described (8). od employed to generate transgeneic mice has involved the Cell Lines and Infection of Embryos. NIH 3T3, XC, and microinjection of recombinant DNA into the zygote Cl-1-lA cells were grown as described (23). The gpt-7-3T3 pronucleus (1-5). Although resulting mouse strains show cell line, derived by infection of NIH 3T3 cells with MSVgpt variable expression of the inserted gene, in a number of virus and Mo-MuLV, has been described (24). Four-to-eight- instances the expected pattern of tissue-specific expression cell mouse embryos were isolated and infected by cocultiva- was observed. A potential alternative to the method of tion with gpt-7-3T3 cells as described (7, 8). Primary Cell Culture. Lung tissue of Mgpt-1 mice was microinjection involves the exposure of early embryos to sliced, rinsed in Dulbecco's phosphate-buffered saline, and retroviruses (6-8). In contrast to the complex, tandemly incubated for 60 min at 370C in Dulbecco's modified Eagle's repeated structure that is frequently observed after introduc- medium supplemented with 10% fetal bovine serum and with tion of DNA into the germ line by microinjection, retroviral and cells infection of preimplantation embryos leads to the stable 0.25% collagenase (Sigma). Bone marrow spleen well-defined that can be were prepared as described (25). integration of single, genomes gpt Virus Assay. Primary lung fibroblasts (2 x 10W) were analyzed easily at the DNA and RNA levels as well as by infected with Mo-MuLV from Cl-i-lA cells. Two weeks assays for viral infectivity. Exposure of preimplantation later, 2 x 10i of these cells were cocultivated for 3 days with mouse embryos to Moloney leukemia virus (Mo-MuLV) 5 x results in efficient integration of proviral sequences into the 105 NIH 3T3 cells in the presence of Polybrene (Aldrich) derived and were subsequently tested for growth in selective medium embryo's genome and into the germ line of animals containing mycophenolic acid (25 ,ug/ml) as selective drug from the infected embryos (6-8). The viral sequences are de (26). novo methylated soon after infection and are not expressed Similarly, 107 bone marrow or spleen cells were coculti- (9). Upon further development of the embryo, these inserted with 2 in vated for 3 days in the presence of Polybrene x 10 proviral sequences remain methylated and suppressed NIH 3T3 cells in RPMI 1640 medium/10% fetal bovine serum most differentiated cells (9). In contrast, retroviruses intro- supplemented with either 10% supernatant from WEHI-3 duced into postimplantation embryos can replicate in an cells (for bone marrow cells) or 50 gg of bacterial lipopoly- unrestricted manner and remain unmethylated in all somatic These media were tissues ofthe developing embryo (for review, see refs. 10 and saccharide per ml (for spleen cells). kindly 11). Abbreviations: Mo-MuLV, Moloney murine leukemia virus; MSVgpt virus, a Mo-MuLV-derived vector containing the Esche- The publication costs of this article were defrayed in part by page charge richia coli gene gpt; SV40, simian virus 40; wt, wild-type. payment. This article must therefore be hereby marked "advertisement" tPresent address: Salk Institute, P.O. Box 85800, San Deigo, CA in accordance with 18 U.S.C. §1734 solely to indicate this fact. 92138. 6927 Downloaded by guest on September 28, 2021 'orf7%28Cell Biology: Rihner et al. Proc. Natl. Acad. Sci. USA 82 (1985) by T. Franz (Heinrich-Pette-Institut). Three days B provided A E P+ S X Pv con- later, the cells were tested for growth under selective a b c d ditions (26). -E } Analysis of DNA and RNA. All restriction enzymes were obtained from Boehringer Mannheim or from Bethesda Research Laboratories and used as recommended by the supplier. Preparation of high molecular weight DNA, elec- trophoresis in 0.8% agarose gels, blotting to nylon mem- branes, and hybridizations were as described (27). Plasmid pSV2 (24) was used to detect gpt and simian virus 40 (SV40) sequences. A BamHII-HindIII fragment from plasmid pL10 (24) served as a gpt-specific probe. al (I) collagen sequences were detected with plasmid HF677 (28). The synthesis of a "Dot cDNA specific for Mo-MuLV has been described (7). .~~~~~~SS i blot" hybridizations were performed with 5 jxg of DNA prepared from tail, and RNA was prepared and analyzed as described (28). gpt [Xanthine (Guanine) Phosphoribosyltransferase, EC 2.4.2.22] Assay. Extracts were prepared from 2-10 x 106 cells by repeated freezing and thawing in 50 mM Tris Cl (pH 7.5). Extract (10 jig of protein) was incubated for 60 min at 370C (29), using ['Cixanthine (Amersham) instead of [14C]gua- FIG. 1. (Upper) Restriction enzyme analyses of mouse 100-19 nine. The amount of [14C]xanthosine 5'-phosphate was de- and its offspring. pSV2 (24) was the hybridization probe (see termined by binding to DEAE plates and measurement of Materials and Methods). (A) EcoRI- and Sst I-digested DNAs from radioactivity in a liquid scintillation counter. liver ofmouse 100-19 (lanes a and b, respectively) and from tail ofone of his first-generation offspring (lanes c and d, respectively). EcoRI does not cleave the MSVgpt provirus (see band E); Sst I cuts in the RESULTS long terminal repeats (open bars in map) to yield bandS (see fragment S above map). Due to incomplete transfer of larger fragments to the nylon membrane, bands generated by EcoRI were less intense than Germ-Line Integration of an MSVgpt Proviral Genome and those derived by Sst I digestion of the same amount of DNA. (B) Derivation of Mice Homozygous at the Mgpt-1 Locus. Analysis of the MSVgpt provirus (see map) in DNA from 100-19 Preimplantation mouse embryos were cocultivated overnight offspring (lanes a) and from the gpt-7-3T3 cell line (lanes b) by the with gpt-7-3T3 cells (7, 8). This cell line produces both enzymes indicated above each pair of lanes: E, EcoRV; P, Pst I; 5, MSVgpt and Mo-MuLV helper virus, the latter at a 10-fold Sst I; X, Xba I; Nv, Pvu II. (Lower) Restriction map of MSVgpt excess (see Table 4). Seven mice were derived from infected provirus. Restriction sites are abbreviated as described above; and tail DNAs were analyzed for the presence of additional sites: A, Ava I. The gpt sequence within the provirus (24) embryos the hatched bar. proviral sequences. Three mice were shown to carry only is indicated by while one animal had Mo- Mo-MuLV helper sequences, named MuLV helper as well as MSVgpt proviral sequences inte- sion of the MSVgpt genome. This proviral locus was grated in its genome. This animal (no. 100-19) was bred with Mgpt-1. normal mice to test for genetic transmission of proviral To derive a mouse strain homozygous for the Mgpt-1 sequences.
Recommended publications
  • Therapeutic Cloning Gives Silenced Genes a Second Voice

    Therapeutic Cloning Gives Silenced Genes a Second Voice

    NEWS p1007 Tricky Fix: p1009 Bohemian p1010 Better than A vaccine for cocaine brain: Neuroscientist Prozac: What’s next in addiction poses John Hardy bucks antidepressant drug ethical dilemmas. the trends. development? Therapeutic cloning gives silenced genes a second voice As controversy continues on therapeutic experiments in Xenopus embryos, is the removal silencing may not be permanent.” cloning to create human embryos, applying the of methyl groups from specific regions of DNA. Jaenisch and his colleagues have also shown technique—also known as somatic cell nuclear This may be a necessary step in the epigenetic that nuclei from a skin cancer cell can be repro- transfer—in animals is generating important reprogramming of the nucleus, the researchers grammed to direct normal development of a insights into disease development. suggest in the October Nature Cell Biology. mouse embryo—meaning that removal of the Some scientists are using the approach to As cells differentiate, they accrue many epigenetic alterations is enough to restore cells study epigenetic alterations—chromosomal other types of epigenetic alterations, such as to normal (Genes Dev.18,1875–1885; 2004).An modifications that do not alter the DNA the addition of phosphates or removal of earlier study reported similar results with brain sequence—which can cause cancer. “A acetyl groups from histones, or chromosomal tumor cells (Cancer Res. 63, 2733–2736; 2003). principal question in cancer research is what proteins, and trigger changes in chromatin Based on such findings, pharmaceutical part of the cancer cell phenotype comes from structure. Defects in these processes have been companies are racing to develop and test ‘epige- genetic defects and what part is epigenetic,”says linked to cancer and other diseases.
  • Liberal Arts Science $600 Million in Support of Undergraduate Science Education

    Liberal Arts Science $600 Million in Support of Undergraduate Science Education

    Janelia Update |||| Roger Tsien |||| Ask a Scientist SUMMER 2004 www.hhmi.org/bulletin LIBERAL ARTS SCIENCE In science and teaching— and preparing future investigators—liberal arts colleges earn an A+. C O N T E N T S Summer 2004 || Volume 17 Number 2 FEATURES 22 10 10 A Wellspring of Scientists [COVER STORY] When it comes to producing science Ph.D.s, liberal arts colleges are at the head of the class. By Christopher Connell 22 Cells Aglow Combining aesthetics with shrewd science, Roger Tsien found a bet- ter way to look at cells—and helped to revolutionize several scientif-ic disciplines. By Diana Steele 28 Night Science Like to take risks and tackle intractable problems? As construction motors on at Janelia Farm, the call is out for venturesome scientists with big research ideas. By Mary Beth Gardiner DEPARTMENTS 02 I N S T I T U T E N E W S HHMI Announces New 34 Investigator Competition | Undergraduate Science: $50 Million in New Grants 03 PRESIDENT’S LETTER The Scientific Apprenticeship U P F R O N T 04 New Discoveries Propel Stem Cell Research 06 Sleeper’s Hold on Science 08 Ask a Scientist 27 I N T E R V I E W Toward Détente on Stem Cell Research 33 G R A N T S Extending hhmi’s Global Outreach | Institute Awards Two Grants for Science Education Programs 34 INSTITUTE NEWS Bye-Bye Bio 101 NEWS & NOTES 36 Saving the Children 37 Six Antigens at a Time 38 The Emergence of Resistance 40 39 Hidden Potential 39 Remembering Santiago 40 Models and Mentors 41 Tracking the Transgenic Fly 42 Conduct Beyond Reproach 43 The 1918 Flu: Case Solved 44 HHMI LAB BOOK 46 N O T A B E N E 49 INSIDE HHMI Dollars and Sense ON THE COVER: Nancy H.
  • About Whitehead Institute for Biomedical Research Selected

    About Whitehead Institute for Biomedical Research Selected

    About Whitehead Institute for Biomedical Research Selected Achievements in FOUNDING VISION Biomedical Science Whitehead Institute is a nonprofit, independent biomedical research institute with pioneering programs in cancer research, developmental biology, genetics, and Isolated the first tumor suppressor genomics. It was founded in 1982 through the generosity of Edwin C. "Jack" Whitehead, gene, the retinoblastoma gene, and a businessman and philanthropist who sought to create a new type of research created the first genetically defined institution, one that would exist outside the boundaries of a traditional academic human cancer cells. (Weinberg) institution, and yet, through a teaching affiliation with the Massachusetts Institute of Technology (MIT), offer all the intellectual, collegial, and scientific benefits of a leading Isolated key genes involved in diabetes, research university. hypertension, leukemia, and obesity. (Lodish) WHITEHEAD INSTITUTE TODAY True to its founding vision, the Institute gives outstanding investigators broad freedom Mapped and cloned the male- to pursue new ideas, encourages novel collaborations among investigators, and determining Y chromosome, revealing a accelerates the path of scientific discovery. Research at Whitehead Institute is unique self-repair mechanism. (Page) conducted by 22 principal investigators (Members and Fellows) and approximately 300 visiting scientists, postdoctoral fellows, graduate students, and undergraduate Developed a method for genetically students from around the world. Whitehead Institute is affiliated with MIT in its engineering salt- and drought-tolerant teaching activities but wholly responsible for its own research programs, governance, plants. (Fink) and finance. Developed the first comprehensive cellular LEADERSHIP network describing how the yeast Whitehead Institute is guided by a distinguished Board of Directors, chaired by Sarah genome produces life.
  • Rudolf Jaenisch

    Rudolf Jaenisch

    Rudolf Jaenisch CURRICULUM VITAE Date of Birth: April 22, 1942 Place of Birth: Wolfelsgrund, Germany Citizenship: United States Education: M.D. 1967, University of Munich, Germany Associations, Memberships and Honors: Member, National Academy of Sciences Fellow, American Academy of Arts and Sciences Member, International Society for Stem Cell Research Member, American Association for the Advancement of Science Member, German Academy of Natural Sciences Leopoldina Associate Member, European Molecular Biology Organization Editorial Board, Developmental Dynamics, 1992-2000 Editorial Board, Development, 1989-1998 Editorial Board, Molecular Reproduction and Development, 1988-1996 1996 Boehringer Mannheim Molecular Bioanalytics Prize 2001 First Peter Gruber Foundation Award in Genetics 2002 Robert Koch Prize for Excellence in Scientific Achievement 2003 Charles Rodolphe Brupracher Foundation Cancer Award 2006 Max Delbrück Medal for Molecular Medicine 2007 Vilcek Foundation Prize for Achievements of Prominent Immigrants 2008 Meira and Shaul G. Massry Prize Professional Experience: 9/68-1/70 Postdoctoral Fellow, Max Planck Institute for Biochemistry, Munich, Germany; research on replication and transcription of E. coli phages M13 and PhiX174. 2/70-2/72 Postdoctoral Fellow with Dr. Arnold Levine, Department of Biochemistry, Princeton University, Princeton, New Jersey. Research on replication, transcription, and transformation with SV40 virus. 2/72-10/72 Visiting Fellow with Dr. Beatrice Mintz, Institute for Cancer Research, Fox Chase, Philadelphia, Pennsylvania Research on the in vitro cultivation and reimplantation of isolated mouse embryos; micromanipulation techniques. 11/72-1/76 Assistant Research Professor, The Salk Institute, La Jolla, CA 1/76-1/77 Associate Research Professor, The Salk Institute, La Jolla, CA Research on the interaction of viruses with early mammalian embryos, generation of first transgenic mice.
  • The Wonderful World of Gene Editing Using CRISPR/Cas9

    The Wonderful World of Gene Editing Using CRISPR/Cas9

    Sponsored by Rheumatic Diseases Core Center (P30-AR048311) & Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC) Please come to the Research in Progress Seminar Series WONDERFUL WORLD OF TECHNOLOGY event featuring Thomas M. Ryan, PhD Associate Professor, Biochemistry & Molecular Genetics The Wonderful World of Gene Editing Using CRISPR/Cas9 Thursday, Feb 5, 2015 12:00 – 1:00 PM SHEL 515, 1825 University Blvd. Raw data welcome! You provide the science, and we’ll provide the food. The Wonderful World of Gene Editing Using CRISPR/Cas9 2/5/2015 Thomas M. Ryan, PhD Biochemistry and Molecular Genetics Regenerative Medicine Patient Transplant back Somatic Cell into patient Biopsy Derive Isogenic In vitro Pluripotent differentiation Stem Cells Corrected Repair DNA Stem Cells lesion Gene Correction by Homologous Recombination in Pluripotent Stem Cells Mouse: Homologous recombination (HR) methodology in murine ES cells is relatively straight forward. Gene targeting (knockouts, knockins, etc.) using targeting constructs with 5’ and 3’ homology regions flanking a selectable marker have been used to modify the mouse genome for over 25 years. Human: Gene correction by HR has proven much more difficult in human ES/iPS cells. Their slower growth and lower plating efficiencies have resulted in only a handful of genes to be targeted by standard techniques. Newer gene correction methods with higher efficiencies are needed. Humanized Hb Mouse Model: Human gA Globin Knock-In LCR ey h0 h1h2 maj min g A hyg CRE ey h0 h1 h2 g A LCR gAKI Mario Capecchi, Martin Evans, and Oliver Smithies were awarded the Noble Prize for Physiology and Medicine in 2007 for this “Gene Targeting” technique.
  • Administration of Barack Obama, 2011 Remarks on Presenting The

    Administration of Barack Obama, 2011 Remarks on Presenting The

    Administration of Barack Obama, 2011 Remarks on Presenting the National Medal of Science and the National Medal of Technology and Innovation October 21, 2011 Welcome, everybody. Please have a seat. It is a great pleasure to be with so many outstanding innovators and inventors. And I'm glad we could convince them all to take a day off—[laughter]—to accept our Nation's highest honor when it comes to inventions and innovation, and that is the National Medals of Science and the National Medals of Technology and Innovation. It's safe to say that this is a group that makes all of us really embarrassed about our old science projects. [Laughter] You know, the volcano with the stuff coming out—[laughter]— with the baking soda inside. Apparently, that was not a cutting-edge achievement— [laughter]—even though our parents told us it was really terrific. But thanks to the men and women on the stage, we are one step closer to curing diseases like cancer and Parkinson's. Because of their work, soldiers can see the enemy at night and grandparents can see the pictures of their grandchildren instantly and constantly. Planes are safer, satellites are cheaper, and our energy grid is more efficient, thanks to the breakthroughs that they have made. And even though these folks have not sought out the kind of celebrity that lands you on the cover of People magazine, the truth is that today's honorees have made a bigger difference in our lives than most of us will ever realize. When we fill up our cars, talk on our cell phones, or take a lifesaving drug, we don't always think about the ideas and the effort that made it all possible.
  • Rudolf Jaenisch

    Rudolf Jaenisch

    RUDOLF JAENISCH Date of Birth: April 22, 1942 Place of Birth: Wolfelsgrund, Germany Citizenship: United States Education: M.D. 1967, University of Munich, Germany Associations, Memberships and Honors: Member, National Academy of Sciences Member, National Institute of Medicine Member, International Society for Stem Cell Research Member, American Association for the Advancement of Science Member, German Academy of Natural Sciences Leopoldina Associate Member, European Molecular Biology Organization Editorial Board, Proceedings of the National Academy of Sciences, 2004- Editorial Board, Developmental Dynamics, 1992-2000 1996 Boehringer Mannheim Molecular Bioanalytics Prize 2001 First Peter Gruber Foundation Award in Genetics 2002 Robert Koch Prize for Excellence in Scientific Achievement 2003 Charles Rodolphe Brupracher Foundation Cancer Award 2006 Max Delbrück Medal for Molecular Medicine 2007 Vilcek Foundation Prize for Achievements of Prominent Immigrants 2008 Meira and Shaul G. Massry Prize 2009 James R. Killian Jr. Faculty Achievement Award 2009 Ernst Schering Prize 2010 Orden Pour le Mérite 2010 Kazemi Prize of the Royan Institute 2010 Order of Merit of the Federal Republic of Germany 2011 MGH Warren Triennial Prize 2011 Wolf Prize for Medicine 2011 United States National Medal of Science 2011 J. Allyn Taylor International Prize in Medicine 2012 ISSCR McEwen Award for Innovation 2012-Vice President, International Society for Stem Cell Research 2013 Franklin Institute Laureate Professional Experience: 9/68-1/70 Postdoctoral Fellow, Max Planck Institute for Biochemistry, Munich; replication and transcription of E. coli phages M13 and PhiX174. 2/70-2/72 Postdoctoral Fellow with Dr. Arnold Levine, Department of Biochemistry, Princeton University; Replication, transcription, and transformation with SV40 virus. 2/72-10/72 Visiting Fellow with Dr.
  • April 8-11, 2019 the 2019 Franklin Institute Laureates the 2019 Franklin Institute AWARDS CONVOCATION APRIL 8–11, 2019

    April 8-11, 2019 the 2019 Franklin Institute Laureates the 2019 Franklin Institute AWARDS CONVOCATION APRIL 8–11, 2019

    april 8-11, 2019 The 2019 Franklin Institute Laureates The 2019 Franklin Institute AWARDS CONVOCATION APRIL 8–11, 2019 Welcome to The Franklin Institute Awards, the range of disciplines. The week culminates in a grand oldest comprehensive science and technology medaling ceremony, befitting the distinction of this awards program in the United States. Each year, the historic awards program. Institute recognizes extraordinary individuals who In this convocation book, you will find a schedule of are shaping our world through their groundbreaking these events and biographies of our 2019 laureates. achievements in science, engineering, and business. We invite you to read about each one and to attend We celebrate them as modern day exemplars of our the events to learn even more. Unless noted otherwise, namesake, Benjamin Franklin, whose impact as a all events are free and open to the public and located scientist, inventor, and statesman remains unmatched in Philadelphia, Pennsylvania. in American history. Along with our laureates, we honor Franklin’s legacy, which has inspired the We hope this year’s remarkable class of laureates Institute’s mission since its inception in 1824. sparks your curiosity as much as they have ours. We look forward to seeing you during The Franklin From shedding light on the mechanisms of human Institute Awards Week. memory to sparking a revolution in machine learning, from sounding the alarm about an environmental crisis to making manufacturing greener, from unlocking the mysteries of cancer to developing revolutionary medical technologies, and from making the world III better connected to steering an industry giant with purpose, this year’s Franklin Institute laureates each reflect Ben Franklin’s trailblazing spirit.
  • 2007 Annual Report

    2007 Annual Report

    At the 25th anniversary kickoff event, Founding Member Robert Weinberg debuts a time capsule that will store Whitehead artifacts. 2007 Annual Report Non-Profit Org. US Postage Whitehead Institute for Biomedical Research PAID Nine Cambridge Center Cambridge, MA Cambridge, Massachusetts 02142-1479 Permit No. 56998 Below: Taken by a deep-ultraviolet microscope, this image shows how the mass of nucleic acids is Whitehead Institute distributed in a mouse macrophage (a kind of immune cell). Image by 2007 Annual Report Benjamin Zeskind, Paul Matsudaira’s laboratory. 1 Director’s letter 3 Scientific highlights 6 Research stories 12 Principal investigators 33 25th anniversary 34 Whitehead news Whitehead Institute for Biomedical Research 36 Public outreach is a nonprofit research and educational institution. Wholly independent in its 38 Financial summary governance, finances and research programs, Whitehead shares a teaching affiliation 40 Leadership with Massachusetts Institute of Technology (MIT). Whitehead brings together a small group of world-class biomedical researchers in a highly collaborative and supportive environment and empowers them to pursue the questions that engage them most. Whitehead Institute for Biomedical Research 9 Cambridge Center on the cover: Studying how cells regulate Cambridge, MA 02142 their growth, David Sabatini’s laboratory 617.258.5000 has shown that Rag family proteins www.whitehead.mit.edu regulate the location of a key protein complex called mTORC1 in the presence of nutrients. Here, mTOR is marked in green, DNA in blue and the Rab7 protein in red. From top to bottom in the sequence here, as the cell is stimulated with amino acids, mTOR moves to be localized in a compartment near the nucleus.
  • March of Dimes Prize in Developmental Biology Recipient List

    March of Dimes Prize in Developmental Biology Recipient List

    MARCH OF DIMES PRIZE IN DEVELOPMENTAL BIOLOGY RECIPIENT LIST 2015 Investigator, Howard Hughes Medical Institute Rudolf Jaenisch, MD Whitehead Institute for Biomedical Research, For pioneering work in human cytogenetics and the normal and and Professor of Biology abnormal function and behavior of the X and Y chromosomes. Massachusetts Institute of Technology, Cambridge, MA 2010 For devising innovative technologies that elucidated long-standing Shinya Yamanaka, MD, PhD * dilemmas in developmental biology, for recognizing the L.K. Whittier Foundation Investigator in Stem Cell Biology transformative significance on cellular function of epigenetic Gladstone Institute of Cardiovascular Disease programming, and for applying the power of induced pluripotent Professor, University of California, San Francisco stem cells to novel discoveries. Director, Center for iPS Cell Research and Application 2014 For research on how certain master genes and protein signals regulate Huda Y. Zoghbi, MD formation and growth of organs such as the brain and limbs during Professor, Departments of Pediatrics; Molecular and Human Genetics; embryonic and fetal development. Neurology; Neuroscience; Programs in Cell and Molecular Biology and Developmental Biology 2009 Baylor College of Medicine, Houston, TX Kevin P. Campbell, PhD Carver Chair, Department of Molecular Physiology & Biophysics For pioneering work evolving from discovery that mutations in the X- Director of the Wellstone Muscular Dystrophy Cooperative Research linked MECP2 cause Rett syndrome and for studies elucidating the Center maintenance role of this epigenetic regulator in different neurons. Professor of Neurology and Internal Medicine 2013 University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Eric Olson, PhD Iowa City, Iowa Annie and Willie Nelson Professorship in Stem Cell Research & Louis M.
  • A Conversation with Rudolf Jaenisch

    A Conversation with Rudolf Jaenisch

    A conversation with Rudolf Jaenisch Ushma S. Neill J Clin Invest. 2015;125(9):3305-3307. https://doi.org/10.1172/JCI82629. Conversations with Giants in Medicine Rudolf Jaenisch of the Whitehead Institute at MIT is a remarkable scientist at the center of the study of epigenetics. Jaenisch (Figure 1) created the very first transgenic mice and did the first experiment showing that therapeutic cloning could correct a genetic defect. He also conducted the first proof of principle experiments with induced pluripotent stem (iPS) cells to correct sickle cell anemia and Parkinson disease in rodents. Hear more of his stories about his first scientific experiments, how to effectively mentor trainees, and his views on the ethics of stem cell use on the JCI website at http://www.jci.org/videos/cgms JCI: What were you like as a kid? Jaenisch: I grew up in Germany, and my parents and my grandparents were medical doctors. I was also interested in medicine. My father was not so sure it was the right thing for me, but he consented and so I went to medical school. I liked part of it, but I didn’t like the more clinical part, as it was overcrowded and one couldn’t get into the lectures. The alternative I came up with was to do an experimental thesis at the Max Planck Institute in Munich on phage replication. It was an interesting time (the 1960s) because it was really the beginning of molecular biology. Bacteria and phages were really the workhorses […] Find the latest version: https://jci.me/82629/pdf CONVERSATIONS WITH GIANTS IN MEDICINE A conversation with Rudolf Jaenisch Rudolf Jaenisch of the Whitehead Insti- his own laboratory at Princeton, working brain because these early cells would, tute at MIT is a remarkable scientist at the on animal viruses.” I wrote to him and of course, contribute to all parts of the center of the study of epigenetics.
  • Genome Editing in Neurosciences Edition Du Génome Et Neurosciences

    Genome Editing in Neurosciences Edition Du Génome Et Neurosciences

    Genome editing in neurosciences Edition du génome et neurosciences Paris - April 22, 2016 Genome editing in neurosciences Paris - April 22, 2016 Innovations in molecular biology are allowing neuroscientists to study the brain with unprecedented resolution, from the level of single molecules to integrated gene circuits. Chief among these innovations is the CRISPR-Cas genome editing technology, which has the precision and scalability to tackle the complexity of the brain. This Colloque Médecine et Recherche brings together experts from around the world that are applying genome editing to address important challenges in neuroscience, including basic biology in model organisms that has the power to reveal systems-level insight into how the nervous system develops and functions as well as research focused on understanding and treating human neurological disorders. We hope that you will join us in Paris for this exciting day to explore how genome editing is advancing neuroscience research and meet some of the leading researchers in this field. Les innovations en biologie moléculaire permettent d’étudier le cerveau avec une résolution inégalée, depuis les molécules jusqu’aux circuits géniques intégrés. La principale innovation concerne une technologie de modification du génome, CRISPR-Cas, qui offre précision et flexibilité afin d’aborder l’étude de la complexité du cerveau. Ce Colloque Médecine et Recherche réunit des experts du monde entier qui utilisent les techniques de genome editing pour répondre à des questions importantes en neuroscience, y compris en biologie fondamentale à partir de l’étude d’organismes modèles, ce qui peut permettre de mieux comprendre le fonctionnement et le développement du système nerveux, mais aussi contribuer à la compréhension et au traitement des troubles neurologiques chez l’homme.